OMX Nordic 40 2729754 / SE0001809476
2’513.95
Pkt
4.79
Pkt
0.19
%
09:31:28
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Nordic 40-Werten
| 12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 07.03.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.03.25 | Novo Nordisk Buy | UBS AG | |
| 03.03.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 28.02.25 | Volvo AB Buy | Deutsche Bank AG | |
| 27.02.25 | ABB Hold | Jefferies & Company Inc. | |
| 26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.02.25 | Volvo AB Buy | UBS AG | |
| 25.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 25.02.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
| 24.02.25 | ABB Neutral | UBS AG | |
| 24.02.25 | ABB Sector Perform | RBC Capital Markets | |
| 24.02.25 | Novo Nordisk Buy | UBS AG | |
| 24.02.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 24.02.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 20.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 20.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 20.02.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 18.02.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | Deutsche Bank AG |